ConductScience.org, home

Paper55529

Levamisole in advanced human breast cancer.

Rojas AF and 4 others. Lancet, 1976. Cited by 175 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Levamisole in advanced human breast cancer. Papers, record 55529. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/55529

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Levamisole in advanced human breast cancer.
PubMed
Journal
Lancet
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
175
iCite
Relative citation ratio, by iCite
6.08
iCite
Revised in PubMed
2019-06-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rojas AFA F
2Feierstein JNJ N
3Mickiewicz EE
4Glait HH
5Olivari AJA J

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
LevamisoleMajor topic
Administration, Oral
Adult
Aged
Clinical Trials as Topic
Female
Follow-Up Studies
Humans
Hypersensitivity, Delayed
Leukocyte Count
Middle Aged
Neoplasm Metastasis
Recurrence
Skin Tests
Time Factors

Source PubMed

Download CSV of topics

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 175 citations.

PMIDTitleJournalYearIn PapersSource
7734336Comparison of splenectomy effects as an indication for host response to growth of primary and metastatic tumour cells in two murine tumour systems.Int J Exp Pathol1995https://conductscience.org/library/papers/7734336PubMed
7396347Inflammatory carcinomas of the breast.Ann R Coll Surg Engl1980https://conductscience.org/library/papers/7396347PubMed
7362777Levamisole: evidence for activity on human haemopoietic progenitor cells.Br J Cancer1980https://conductscience.org/library/papers/7362777PubMed
7253782Current aspects of immunotherapy in cancer.Langenbecks Arch Chir1981https://conductscience.org/library/papers/7253782PubMed
6961950Regulation of human natural killing by levamisole.Cancer Immunol Immunother1982https://conductscience.org/library/papers/6961950PubMed
6553512Restoration by levamisole of immune responses suppressed in tumor-bearing mice.Cancer Immunol Immunother1983https://conductscience.org/library/papers/6553512PubMed
6423870Effects of Levamisole in adjuvant immunochemotherapy for gastric cancer; a prospective randomized controlled study.Jpn J Surg1983https://conductscience.org/library/papers/6423870PubMed
3893336Need for immunologic stimulators during immunosuppression produced by major cancer surgery.Ann Surg1985https://conductscience.org/library/papers/3893336PubMed
847983Adjuvant treatment of colorectal cancer.West J Med1977https://conductscience.org/library/papers/847983PubMed
847975Cancer and the immunity system--1977.West J Med1977https://conductscience.org/library/papers/847975PubMed
791447Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG.Br Med J1976https://conductscience.org/library/papers/791447PubMed
686870Neutropenia during treatment of rheumatoid arthritis with levamisole.Ann Rheum Dis1978https://conductscience.org/library/papers/686870PubMed
680948Restoration of methotrexate-suppressed oxazolone-induced contact sensitivity with levamisole.Inflammation1978https://conductscience.org/library/papers/680948PubMed
617957Condition-dependent immunoregulatory control of contact sensitivity by levamisole.Inflammation1977https://conductscience.org/library/papers/617957PubMed
602232Immunotherapy as an adjunct to surgery in the treatment of cancer.World J Surg1977https://conductscience.org/library/papers/602232PubMed
435650No effects of levamisole on cytotoxic drug-induced changes of human granulopoiesis.Blut1979https://conductscience.org/library/papers/435650PubMed
376044Mammary cancers and pregnancy.Br Med J1979https://conductscience.org/library/papers/376044PubMed
373908Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer.Cancer Chemother Pharmacol1978https://conductscience.org/library/papers/373908PubMed
340236Effect of libexin combinatum (libexine and emetine) on phagocytosis by polymorphonuclear granulocytes and alveolar macrophages.Eur J Clin Pharmacol1977https://conductscience.org/library/papers/340236PubMed
324919Alveolar macrophage-lymphocyte rosette formation: failure of levamisole to alter activity.Infect Immun1977https://conductscience.org/library/papers/324919PubMed

See all 24 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/55529

GET https://conductscience.org/api/papers/v1/55529/cited_by?page=2